Disease-specific suppressive granulocytes participate in glioma progression

Summary: Glioblastoma represents one of the most aggressive cancers, characterized by severely limited therapeutic options. Despite extensive investigations into this brain malignancy, cellular and molecular components governing its immunosuppressive microenvironment remain incompletely understood....

Full description

Saved in:
Bibliographic Details
Main Authors: Jiarui Zhao, Di Wu, Jiaqi Liu, Yang Zhang, Chunzhao Li, Weichen Zhao, Penghui Cao, Shixuan Wu, Mengyuan Li, Wenlong Li, Ying Liu, Yingying Huang, Ying Cao, Yiwen Sun, Ence Yang, Nan Ji, Jing Yang, Jian Chen
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Cell Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2211124724013652
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846140733269999616
author Jiarui Zhao
Di Wu
Jiaqi Liu
Yang Zhang
Chunzhao Li
Weichen Zhao
Penghui Cao
Shixuan Wu
Mengyuan Li
Wenlong Li
Ying Liu
Yingying Huang
Ying Cao
Yiwen Sun
Ence Yang
Nan Ji
Jing Yang
Jian Chen
author_facet Jiarui Zhao
Di Wu
Jiaqi Liu
Yang Zhang
Chunzhao Li
Weichen Zhao
Penghui Cao
Shixuan Wu
Mengyuan Li
Wenlong Li
Ying Liu
Yingying Huang
Ying Cao
Yiwen Sun
Ence Yang
Nan Ji
Jing Yang
Jian Chen
author_sort Jiarui Zhao
collection DOAJ
description Summary: Glioblastoma represents one of the most aggressive cancers, characterized by severely limited therapeutic options. Despite extensive investigations into this brain malignancy, cellular and molecular components governing its immunosuppressive microenvironment remain incompletely understood. Here, we identify a distinct neutrophil subpopulation, termed disease-specific suppressive granulocytes (DSSGs), present in human glioblastoma and lower-grade gliomas. DSSGs exhibit the concurrent expression of multiple immunosuppressive and immunomodulatory signals, and their abundance strongly correlates with glioma grades and poor clinical outcomes. Genetic disruption of neutrophil recruitment in immunocompetent mouse models of gliomas, achieved through Cxcl1 knockout in glioma cells or host-specific Cxcr2 deletion or diphtheria toxin A-mediated neutrophil depletion, can significantly enhance antitumor immunity and prolong survival. Further, we reveal that the skull bone marrow and meninges can be the primary sources of neutrophils and DSSGs in human and mouse glioma tumors. These findings demonstrate a critical mechanism underlying the establishment of the immunosuppressive microenvironment in gliomas.
format Article
id doaj-art-e4cb5418db7f407fa1440c88c5f4837f
institution Kabale University
issn 2211-1247
language English
publishDate 2024-12-01
publisher Elsevier
record_format Article
series Cell Reports
spelling doaj-art-e4cb5418db7f407fa1440c88c5f4837f2024-12-05T05:20:17ZengElsevierCell Reports2211-12472024-12-014312115014Disease-specific suppressive granulocytes participate in glioma progressionJiarui Zhao0Di Wu1Jiaqi Liu2Yang Zhang3Chunzhao Li4Weichen Zhao5Penghui Cao6Shixuan Wu7Mengyuan Li8Wenlong Li9Ying Liu10Yingying Huang11Ying Cao12Yiwen Sun13Ence Yang14Nan Ji15Jing Yang16Jian Chen17Beijing Institute for Brain Research, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 102206, China; Chinese Institute for Brain Research, Beijing, Beijing 102206, ChinaBeijing Institute for Brain Research, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 102206, China; Chinese Institute for Brain Research, Beijing, Beijing 102206, ChinaState Key Laboratory of Membrane Biology, School of Life Sciences, Peking University, Beijing 100871, ChinaDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China; China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, ChinaDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China; China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, ChinaChangping Laboratory, Beijing 102206, ChinaBeijing Institute for Brain Research, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 102206, China; Chinese Institute for Brain Research, Beijing, Beijing 102206, ChinaBeijing Institute for Brain Research, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 102206, China; Chinese Institute for Brain Research, Beijing, Beijing 102206, ChinaBeijing Institute for Brain Research, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 102206, China; Chinese Institute for Brain Research, Beijing, Beijing 102206, ChinaBeijing Institute for Brain Research, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 102206, China; Chinese Institute for Brain Research, Beijing, Beijing 102206, ChinaState Key Laboratory of Membrane Biology, School of Life Sciences, Peking University, Beijing 100871, ChinaState Key Laboratory of Membrane Biology, School of Life Sciences, Peking University, Beijing 100871, ChinaCenter for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, ChinaBeijing Institute for Brain Research, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 102206, China; Chinese Institute for Brain Research, Beijing, Beijing 102206, ChinaDepartment of Medical Bioinformatics, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, ChinaDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China; China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China; Corresponding authorState Key Laboratory of Membrane Biology, School of Life Sciences, Peking University, Beijing 100871, China; Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China; IDG/McGovern Institute for Brain Research, Peking University, Beijing 100871, China; Peking University Third Hospital Cancer Center, Beijing 100191, China; Corresponding authorBeijing Institute for Brain Research, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 102206, China; Chinese Institute for Brain Research, Beijing, Beijing 102206, China; Changping Laboratory, Beijing 102206, China; Corresponding authorSummary: Glioblastoma represents one of the most aggressive cancers, characterized by severely limited therapeutic options. Despite extensive investigations into this brain malignancy, cellular and molecular components governing its immunosuppressive microenvironment remain incompletely understood. Here, we identify a distinct neutrophil subpopulation, termed disease-specific suppressive granulocytes (DSSGs), present in human glioblastoma and lower-grade gliomas. DSSGs exhibit the concurrent expression of multiple immunosuppressive and immunomodulatory signals, and their abundance strongly correlates with glioma grades and poor clinical outcomes. Genetic disruption of neutrophil recruitment in immunocompetent mouse models of gliomas, achieved through Cxcl1 knockout in glioma cells or host-specific Cxcr2 deletion or diphtheria toxin A-mediated neutrophil depletion, can significantly enhance antitumor immunity and prolong survival. Further, we reveal that the skull bone marrow and meninges can be the primary sources of neutrophils and DSSGs in human and mouse glioma tumors. These findings demonstrate a critical mechanism underlying the establishment of the immunosuppressive microenvironment in gliomas.http://www.sciencedirect.com/science/article/pii/S2211124724013652CP: Cancer
spellingShingle Jiarui Zhao
Di Wu
Jiaqi Liu
Yang Zhang
Chunzhao Li
Weichen Zhao
Penghui Cao
Shixuan Wu
Mengyuan Li
Wenlong Li
Ying Liu
Yingying Huang
Ying Cao
Yiwen Sun
Ence Yang
Nan Ji
Jing Yang
Jian Chen
Disease-specific suppressive granulocytes participate in glioma progression
Cell Reports
CP: Cancer
title Disease-specific suppressive granulocytes participate in glioma progression
title_full Disease-specific suppressive granulocytes participate in glioma progression
title_fullStr Disease-specific suppressive granulocytes participate in glioma progression
title_full_unstemmed Disease-specific suppressive granulocytes participate in glioma progression
title_short Disease-specific suppressive granulocytes participate in glioma progression
title_sort disease specific suppressive granulocytes participate in glioma progression
topic CP: Cancer
url http://www.sciencedirect.com/science/article/pii/S2211124724013652
work_keys_str_mv AT jiaruizhao diseasespecificsuppressivegranulocytesparticipateingliomaprogression
AT diwu diseasespecificsuppressivegranulocytesparticipateingliomaprogression
AT jiaqiliu diseasespecificsuppressivegranulocytesparticipateingliomaprogression
AT yangzhang diseasespecificsuppressivegranulocytesparticipateingliomaprogression
AT chunzhaoli diseasespecificsuppressivegranulocytesparticipateingliomaprogression
AT weichenzhao diseasespecificsuppressivegranulocytesparticipateingliomaprogression
AT penghuicao diseasespecificsuppressivegranulocytesparticipateingliomaprogression
AT shixuanwu diseasespecificsuppressivegranulocytesparticipateingliomaprogression
AT mengyuanli diseasespecificsuppressivegranulocytesparticipateingliomaprogression
AT wenlongli diseasespecificsuppressivegranulocytesparticipateingliomaprogression
AT yingliu diseasespecificsuppressivegranulocytesparticipateingliomaprogression
AT yingyinghuang diseasespecificsuppressivegranulocytesparticipateingliomaprogression
AT yingcao diseasespecificsuppressivegranulocytesparticipateingliomaprogression
AT yiwensun diseasespecificsuppressivegranulocytesparticipateingliomaprogression
AT enceyang diseasespecificsuppressivegranulocytesparticipateingliomaprogression
AT nanji diseasespecificsuppressivegranulocytesparticipateingliomaprogression
AT jingyang diseasespecificsuppressivegranulocytesparticipateingliomaprogression
AT jianchen diseasespecificsuppressivegranulocytesparticipateingliomaprogression